1. Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection

   • Amjad Alfaleh
   • Abdullah Alkattan
   • Mona Ibrahim

   Original Research Article 30 August 2022 Pages: 799 - 806

   

2. Reporting of COVID-19 Reinfection and Potential Role of Immunosuppressant/Immunomodulating Agents: A Cross-Sectional Observational Analysis Based on a Spontaneous Reporting Database

   • Elena Beyzarov
   • Yan Chen
   • Patrick Caubel

   Original Research Article Open access 14 September 2022 Pages: 807 - 812

3. Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan

   • Derar H. Abdel-Qader
   • Hasan Abdel-Qader
   • Mohammad Asad

   Original Research Article 23 August 2022 Pages: 813 - 827

   

4. Evaluation of the Effect of Uridine Diphosphate-Glucuronosyltransferases (UGT) Inhibition by Valproic Acid on Vixotrigine Pharmacokinetics in Healthy Volunteers

   • Yuan Zhao
   • Mona Kotecha
   • Himanshu Naik

   Original Research Article 31 August 2022 Pages: 829 - 837

   

5. Cost-Utility Analysis of CYP2C19 Genotype Detection for Selection of Acid-Suppressive Therapy with Lansoprazole or Vonoprazan for Patients with Reflux Esophagitis in China

   • Zhuolin Zhang
   • Yuwen Bao
   • Xin Li

   Original Research Article 22 August 2022 Pages: 839 - 851

   

6. Healthcare Utilization of Patients with Opioid Use Disorder in US Hospitals from 2016 to 2019: Focusing on Racial and Regional Variances

   • Sun Jung Kim
   • Mar Medina
   • Jongwha Chang

   Original Research Article 24 August 2022 Pages: 853 - 863

   

7. Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression

   • Juliana Surjan
   • Julia Diniz Grossi
   • Acioly Luiz Tavares Lacerda

   Original Research Article 31 August 2022 Pages: 865 - 873

   

8. AVT02: An Adalimumab Biosimilar

   • Connie Kang

   Adis Biosimilar Brief Open access 01 October 2022 Pages: 875 - 878